A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease - Concepedia

Concepedia

Publication | Closed Access

A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease

740

Citations

31

References

2008

Year

William J. Sandborn, Brian G. Feagan, Richard N. Fedorak, Ellen Scherl, Mark R. Fleisher, Seymour Katz, Jewel Johanns, Marion Blank, Paul Rutgeerts

Gastroenterology

InflammationAllergyAutoimmune DiseaseImmunologyGastroenterologyModerate-to-severe CrohnAutoimmunityInflammatory Rheumatic DiseaseRandomized TrialUlcerative ColitisMedicine

References

	Year	Citations

Page 1

Page 1